Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medx Health's share price for the quarter that ended in Sep. 2024 was $0.0284. Medx Health's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 270.17 Mil. Therefore, Medx Health's market cap for the quarter that ended in Sep. 2024 was $7.67 Mil.
Medx Health's quarterly market cap
increased
from Mar. 2024 ($9.17 Mil) to Jun. 2024 ($14.82 Mil) but then
declined
from Jun. 2024 ($14.82 Mil) to Sep. 2024 ($7.67 Mil).
Medx Health's annual market cap
declined
from Dec. 2021 ($10.32 Mil) to Dec. 2022 ($3.31 Mil) but then
increased
from Dec. 2022 ($3.31 Mil) to Dec. 2023 ($9.17 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medx Health's Enterprise Value for Today is $16.34 Mil.
Medx Health Market Cap Historical Data
The historical data trend for Medx Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medx Health's Market Cap
For the Medical Devices subindustry, Medx Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medx Health's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medx Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Medx Health's Market Cap falls into.
Medx Health Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Medx Health's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medx Health (OTCPK:MDXHF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Medx Health Market Cap Related Terms
Thank you for viewing the detailed overview of Medx Health's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Medx Health Corp is engaged in the development, manufacturing, and marketing of skin-related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. The company sells its products internationally, of which prime revenue is generated in Canada and the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MDXHF has been successfully added to your 